MUSTANG BIO, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MUSTANG BIO, INC. (MBIO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.34 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.34M shares, a 38.43% decline year-over-year.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 7.06M shares, a 11498.88% increase year-over-year.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 60.83K shares, a 89.70% decline year-over-year.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 590.62K shares, a 8.74% increase year-over-year.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.68M shares, a 196.25% increase from fiscal 2024.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.58M shares, a 2477.64% increase from fiscal 2023.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 61.30K shares, a 89.72% decline from fiscal 2022.
- MUSTANG BIO, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 596.24K shares, a 91.85% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.34M shares 10-Q · filed 2026-08-05 | |||||||
| 2026-03-31 | 4.34M shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 4.68M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 4.68M shares 10-Q · filed 2025-11-07 | |||||||
| 2025-06-30 | 7.05M shares 10-Q · filed 2026-08-05 | |||||||
| 2025-03-31 | 7.06M shares 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | 1.58M shares 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | 1.22M shares 10-Q · filed 2025-11-07 | 61.35M shares 10-Q · filed 2024-11-08 | ||||||
| 2024-06-30 | 1.22M shares 10-Q · filed 2025-08-08 | 61.36M shares 10-Q · filed 2024-08-13 | ||||||
| 2024-03-31 | 60.83K shares 10-Q · filed 2025-05-14 | 3.28M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 61.30K shares 10-K · filed 2025-03-28 | 3.30M shares 10-K · filed 2024-03-11 | ||||||
| 2023-09-30 | 567.02K shares 10-Q · filed 2024-11-08 | |||||||
| 2023-06-30 | 559.71K shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 590.62K shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 596.24K shares 10-K · filed 2024-03-11 | 5.44M shares 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | 594.92K shares 10-Q · filed 2023-11-14 | 5.42M shares 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | 571.55K shares 10-Q · filed 2023-08-14 | 5.07M shares 10-Q · filed 2022-08-11 | ||||||
| 2022-03-31 | 543.16K shares 10-Q · filed 2023-05-12 | 4.65M shares 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | 7.32M shares 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | 8.38M shares 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | 9.16M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 8.94M shares 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | 8.57M shares 10-K · filed 2022-03-23 | |||||||
| 2020-09-30 | 8.60M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 8.51M shares 10-Q · filed 2021-08-16 | 8.51M shares 10-Q · filed 2020-08-10 | ||||||
| 2020-03-31 | 8.17M shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 8.31M shares 10-K · filed 2021-03-24 | |||||||
| 2019-09-30 | 8.40M shares 10-Q · filed 2020-11-06 | |||||||
| 2019-06-30 | 8.45M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 8.19M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 8.24M shares 10-K · filed 2020-03-16 | |||||||
| 2018-09-30 | 7.65M shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |